
The health ministry also informed that more time was requested on behalf of Pfizer.
#IndiaFightsCorona #Unite2FightCorona
The Subject Expert Committee (SEC) met today to consider the Emergency Use Authorization request from @pfizer @SerumInstIndia & @BharatBiotech and is scheduled to reconvene on 1st Jan 2021.https://t.co/bXrNWYJ4Ad pic.twitter.com/p6rRdztC4X
— Ministry of Health (@MoHFW_INDIA) December 30, 2020
Also, the additional data and information presented by the Serum Institute of India and Bharat Biotech Pvt Ltd was perused and analysed by SEC.
The analysis of the additional data and information is going on, the health ministry release further added.
The Subject Expert Committee will convene again on Friday – January 1, 2021, the health ministry further informed.
More details awaited.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.